Skip to main content
Fig. 2 | BioMedical Engineering OnLine

Fig. 2

From: A comprehensive analysis of potential gastric cancer prognostic biomarker ITGBL1 associated with immune infiltration and epithelial–mesenchymal transition

Fig. 2

Experimental verification of ITGBL1 expression level. AC qRT–PCR was conducted to detect ITGBL1 mRNA expression in 13 GC samples as fold change (A) and normalized to GAPDH expression (B). Results showed that 61.5% (8/13) of patients with GC had high expression of ITGBL1 (C). D, F Immunohistochemical staining of ITGBL1 for 30 paired patients with GC. Representative images of normal and tumor tissues are shown; scale bar: 10 µm (D); 63.3% of patients with ITGBL1-positive expression in GC tissues (E). Results of ITGBL1 IHC scores in GC compared with paired nontumor tissues (F). *P < 0.05, **P < 0.01

Back to article page